Literature DB >> 11930902

Overexpression of IL-17 in the knee joint of collagen type II immunized mice promotes collagen arthritis and aggravates joint destruction.

E Lubberts1, L A B Joosten, F A J van de Loo, P Schwarzenberger, J Kolls, W B van den Berg.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11930902     DOI： 10.1007/BF02684010

Source DB:  PubMed          Journal:  Inflamm Res        ISSN： 1023-3830            Impact factor:   4.575


× No keyword cloud information.
  6 in total

1.  IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis.

Authors:  S Kotake; N Udagawa; N Takahashi; K Matsuzaki; K Itoh; S Ishiyama; S Saito; K Inoue; N Kamatani; M T Gillespie; T J Martin; T Suda
Journal:  J Clin Invest       Date:  1999-05       Impact factor: 14.808

2.  Reduction of interleukin-17-induced inhibition of chondrocyte proteoglycan synthesis in intact murine articular cartilage by interleukin-4.

Authors:  E Lubberts; L A Joosten; F A van de Loo; L A van den Gersselaar; W B van den Berg
Journal:  Arthritis Rheum       Date:  2000-06

3.  Human interleukin-17: A T cell-derived proinflammatory cytokine produced by the rheumatoid synovium.

Authors:  M Chabaud; J M Durand; N Buchs; F Fossiez; G Page; L Frappart; P Miossec
Journal:  Arthritis Rheum       Date:  1999-05

4.  Adenoviral vector-mediated overexpression of IL-4 in the knee joint of mice with collagen-induced arthritis prevents cartilage destruction.

Authors:  E Lubberts; L A Joosten; L van Den Bersselaar; M M Helsen; A C Bakker; J B van Meurs; F L Graham; C D Richards; W B van Den Berg
Journal:  J Immunol       Date:  1999-10-15       Impact factor: 5.422

5.  Human IL-17: a novel cytokine derived from T cells.

Authors:  Z Yao; S L Painter; W C Fanslow; D Ulrich; B M Macduff; M K Spriggs; R J Armitage
Journal:  J Immunol       Date:  1995-12-15       Impact factor: 5.422

6.  T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines.

Authors:  F Fossiez; O Djossou; P Chomarat; L Flores-Romo; S Ait-Yahia; C Maat; J J Pin; P Garrone; E Garcia; S Saeland; D Blanchard; C Gaillard; B Das Mahapatra; E Rouvier; P Golstein; J Banchereau; S Lebecque
Journal:  J Exp Med       Date:  1996-06-01       Impact factor: 14.307
  6 in total
  60 in total

1.  LACC1 Regulates TNF and IL-17 in Mouse Models of Arthritis and Inflammation.

Authors:  Cara Skon-Hegg; Juan Zhang; Xiumin Wu; Meredith Sagolla; Naruhisa Ota; Arthur Wuster; Jennifer Tom; Emma Doran; Nandhini Ramamoorthi; Patrick Caplazi; John Monroe; Wyne P Lee; Timothy W Behrens
Journal:  J Immunol       Date:  2018-12-03       Impact factor: 5.422

2.  Decreased collagen-induced arthritis severity and adaptive immunity in MKK-6-deficient mice.

Authors:  Deepa Hammaker; Katharyn Topolewski; Meghan Edgar; Toshio Yoshizawa; Akihisa Fukushima; David L Boyle; Esther Cory Burak; Robert L Sah; Gary S Firestein
Journal:  Arthritis Rheum       Date:  2012-03

3.  An essential role for IL-17 in preventing pathogen-initiated bone destruction: recruitment of neutrophils to inflamed bone requires IL-17 receptor-dependent signals.

Authors:  Jeffrey J Yu; Matthew J Ruddy; Grace C Wong; Cornelia Sfintescu; Pamela J Baker; Jeffrey B Smith; Richard T Evans; Sarah L Gaffen
Journal:  Blood       Date:  2007-01-03       Impact factor: 22.113

4.  Mucosal administration of an altered CII263-272 peptide inhibits collagen-induced arthritis by suppression of Th1/Th17 cells and expansion of regulatory T cells.

Authors:  Jinxia Zhao; Ru Li; Jing He; Jinxia Shi; Li Long; Zhanguo Li
Journal:  Rheumatol Int       Date:  2008-07-05       Impact factor: 2.631

5.  Targeted depletion of lymphotoxin-alpha-expressing TH1 and TH17 cells inhibits autoimmune disease.

Authors:  Eugene Y Chiang; Ganesh A Kolumam; Xin Yu; Michelle Francesco; Sinisa Ivelja; Ivan Peng; Peter Gribling; Jean Shu; Wyne P Lee; Canio J Refino; Mercedesz Balazs; Andres Paler-Martinez; Allen Nguyen; Judy Young; Kai H Barck; Richard A D Carano; Ron Ferrando; Lauri Diehl; Devavani Chatterjea; Jane L Grogan
Journal:  Nat Med       Date:  2009-06-28       Impact factor: 53.440

Review 6.  The IL-17 family cytokines in immunity and disease.

Authors:  Rajita Pappu; Vladimir Ramirez-Carrozzi; Naruhisa Ota; Wenjun Ouyang; Yan Hu
Journal:  J Clin Immunol       Date:  2010-02-23       Impact factor: 8.317

Review 7.  The interleukin-17 cytokine family: critical players in host defence and inflammatory diseases.

Authors:  Rajita Pappu; Vladimir Ramirez-Carrozzi; Arivazhagan Sambandam
Journal:  Immunology       Date:  2011-07-04       Impact factor: 7.397

8.  Development of proteoglycan-induced arthritis is independent of IL-17.

Authors:  Paul D Doodes; Yanxia Cao; Keith M Hamel; Yumei Wang; Balint Farkas; Yoichiro Iwakura; Alison Finnegan
Journal:  J Immunol       Date:  2008-07-01       Impact factor: 5.422

9.  Program Death-1 Suppresses Autoimmune Arthritis by Inhibiting Th17 Response.

Authors:  Lifen Yang; Guilin Qiao; Yassir Hassan; Zhenping Li; Xiaoqing Zhang; Huimin Kong; Weimin Zeng; Fei Yin; Jian Zhang
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2016-05-19       Impact factor: 4.291

10.  T-helper 17 lymphocytes in ocular cicatricial pemphigoid.

Authors:  Alessandro Lambiase; Alessandra Micera; Flavio Mantelli; Caterina Moretti; Antonio Di Zazzo; Eleonora Perrella; Sergio Bonini; Stefano Bonini
Journal:  Mol Vis       Date:  2009-07-28       Impact factor: 2.367
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.